LR 10.8 Miscellaneous

1. (1)

   A listed company in severe financial difficulty may find itself with no alternative but to dispose of a substantial part of its business within a short time frame to meet its ongoing working capital requirements or to reduce its liabilities. Due to time constraints it may not be able to prepare a circular and convene an extraordinary general meeting to obtain prior shareholder approval.

2. (2)

   The FSA may modify the requirements in LR 10.5 to prepare a circular and to obtain shareholder approval for such a disposal, if the company:

   1. (a)

      can demonstrate that it is in severe financial difficulty; and

   2. (b)

      satisfies the conditions in LR 10.8.2 G to LR 10.8.6 G.

3. (3)

   An application to modify LR 10.5 should be brought to the FSA's attention at the earliest available opportunity and at least five clear business days before the terms of the disposal are agreed.

The listed company should demonstrate to the FSA that it could not reasonably have entered into negotiations earlier to enable shareholder approval to be sought.

The following documents should be provided in writing to the FSA:

1. (1)

   confirmation from the listed company that:

   1. (a)

      negotiation does not allow time for shareholder approval;

   2. (b)

      all alternative methods of financing have been exhausted and the only option remaining is to dispose of a substantial part of their business;

   3. (c)

      by taking the decision to dispose of part of the business to raise cash, the directors are acting in the best interests of the company and shareholders as a whole and that unless the disposal is completed receivers, administrators or liquidators are likely to be appointed; and

   4. (d)

      if the disposal is to a related party, that the disposal by the company to the related party is the only available option in the current circumstances.

2. (2)

   confirmation from the company's sponsor that, in its opinion and on the basis of information available to it, the company is in severe financial difficulty and that it will not be in a position to meet its obligations as they fall due unless the disposal takes place according to the proposed timetable;

3. (3)

   confirmation from the persons providing finance stating that further finance or facilities will not be made available and that unless the disposal is effected immediately, current facilities will be withdrawn; and

4. (4)

   an announcement that complies with LR 10.8.4 G and LR 10.8.5 G.

An announcement should be notified to a RIS no later than the date the terms of the disposal are agreed and should contain:

1. (1)

   all relevant information required to be notified under LR 10.4.1 R;

2. (2)

   the name of the acquirer and the expected date of completion of the disposal;

3. (3)

   full disclosure about the continuing groups prospects for at least the current financial year;

4. (4)

   a statement that the directors believe that the disposal is in the best interests of the company and shareholders as a whole. The directors should also state that if the disposal is not completed the company will be unable to meet its financial commitments as they fall due and consequently will be unable to continue to trade resulting in the appointment of receivers, liquidators or administrators;

5. (5)

   a statement incorporating the details of all the confirmations provided to the FSA in LR 10.8.3 G;

6. (6)

   details of any financing arrangements (either current or future) if they are contingent upon the disposal being effected;

7. (7)

   if the disposal is to a related party, then a statement as set out in LR 13.6.1R(5) must be given;

8. (8)

   a statement by the listed company that in its opinion the working capital available to the continuing group is sufficient for the groups present requirements, that is, for at least 12 months from the date of the announcement, or, if not, how it is proposed to provide the additional working capital thought by the company to be necessary.

The announcement should contain any further information that the company and its sponsors consider necessary. This should incorporate historical price sensitive information, which has already been published in relation to the disposal along with any further information required to be disclosed under DTR 2 (disclosure of inside information).

1. (1)

   The FSA will wish to examine the documents referred to in LR 10.8.3 G (including the RIS announcement) before it grants the modification and before the announcement is released.

2. (2)

   The documents should ordinarily be lodged with the FSA:

   1. (a)

      in draft form at least five clear business days before the terms of the transaction are agreed; and

   2. (b)

      in final form on the day on which approval is sought.

In relation to the listed company's financial position, DTR 2 (disclosure of inside information) continues to apply while the company is seeking a modification.

The directors should also consider whether the listed company's financial situation is such that they should request the suspension of its listing pending publication of an announcement and clarification of its financial position.

1. (1)

   When a listed company enters into a joint venture it should consider how this chapter applies.

2. (2)

   It is common, when entering into a joint venture, for the partners to include exit provisions in the terms of the agreement. These typically give each partner a combination of rights and obligations to either sell their own holding or to acquire their partner's holding should certain triggering events occur.

3. (3)

   If the listed company does not retain sole discretion over the event which requires them to either purchase the joint venture partner's stake or to sell their own, LR 10.1.3R (2) requires this obligation to be classified at the time it is agreed as though it had been exercised at that time. Further, if the consideration to be paid is to be determined by reference to the future profitability of the joint venture or an independent valuation at the time of exercise, this consideration will be treated as being uncapped. If this is the case, the initial agreement will be classifiedas a class 1 transaction at the time it is entered into.

4. (4)

   If the listed company does retain sole discretion over the triggering event, or if the listed company is making a choice to purchase or sell following an event which has been triggered by the joint venture partner, the purchase or sale must be classified when this discretion is exercised or when the choice to purchase or sell is made.

   1